Contract Manufacturing

© Rentschler Biopharma

Rentschler Biopharma: ‘Our strength is in our niche’

By Isabel Cameron

As the global contract development and manufacturing organization (CDMO) market continues to grow, we caught up with Federico Pollano, SVP business development at Rentschler Biopharma, at Bio International 2023, to discuss the company's ongoing growth...

© GettyImages/Cecilie_Arcurs

Novartis inks contract manufacturing deal with Carisma

By Jane Byrne

Novartis continues down the third-party manufacturing route, as it secures an agreement with Carisma Therapeutics, a firm developing a cell therapy platform focused on engineered macrophage-based therapeutics.

(RUNSTUDIO/iStock via Getty Images Plus)

CPHI NORTH AMERICA 2021

M&A activity vigorous in CDMO arena: CPhI

By Jenni Spinner

An expert speaking during the industry event offers insight and perspective on the flurry of CDMO deal-making in recent months, and what might lie ahead.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All